Amgen Inc. (AMGN) financial statements and ratios from SEC XBRL: revenue $36.75B (TTM), net margin 21.0%, revenue growth 5.8% YoY, P/E 30.0. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $36.75B |
| Net Margin | 21.0% |
| Revenue Growth (YoY) | 5.8% |
| EPS Growth (YoY) | 4.7% |
| FCF Growth (YoY) | 50.7% |
| P/E Ratio | 30.0 |
| EV / EBITDA | 18.1 |
| Price / Book | 25.47 |
| Price / Sales | 6.29 |
| FCF Yield | 2.4% |
| DCF Value (model) | $101.46 |
| DCF Upside vs Price | -76.6% |
| Altman Z-Score | 2.11 (grey) |
| Piotroski F-Score | 7/9 |
| Sector P/E (Healthcare) | 21.6 |
AMGN overview · AMGN earnings · AMGN KPIs · AMGN investor relations · AMGN ownership · AMGN peers · AMGN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.